Labshake search
Citations for Bio X Cell :
1 - 50 of 516 citations for 7 methoxy 4 piperidin 1 ium 1 ylmethyl 3 4 dihydro 2H 1 benzoxepin 5 one chloride since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Immunology 2023Quote: ... into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems) plus anti-IL-4 (10 μg mL-1, BioXcell), or Th17 – rhTGFβ (3 ng mL-1 ...
-
bioRxiv - Immunology 2020Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-murine PD-1 and anti-murine CTLA-4 were purchased from Bio X Cell (BE0146-clone RMP1-14 ...
-
bioRxiv - Immunology 2023Quote: ... and 5 ug JES6-1 (BioXcell) intraperitoneally on days 2-4 post-infection in a total volume of 200 uL ...
-
bioRxiv - Immunology 2021Quote: ... CTLs were pre-incubated with LFA-1 blocking antibody (20 μg/mL, Clone M17/4, BioXCell) or an IgG2aκ isotype control antibody (20 μg/mL ...
-
bioRxiv - Microbiology 2021Quote: ... naïve CD4+ T cells were cultured with 10 ng·ml-1 IL-12 (R&D, Cat# 402-ML-020/CF) and 10 μg·ml-1 anti-IL-4 (Bio X Cell, Cat# BE0045, RRID:AB_1107707). For Th17 cell differentiation ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2023Quote: ... or Th17 – rhTGFβ (3 ng mL-1, Miltenyi) + rmIL-6 (20 ng mL-1, Miltenyi) + anti-IFNγ (10 μg mL-1, BioXcell). Cells were then transferred to uncoated tissue culture plates and cultured for an additional 3 days ...
-
bioRxiv - Immunology 2022Quote: ... and then transferred to a 96 well plate that had been coated overnight at 4°C with 5µg/ml αCD3 (BE0001-1, BioXcell), 5µg/ml CD80-Fc (555404 ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-TIM3 Ab (4 μg/ml, clone RMT-3-23, BioXCell, Lebanon, NH), or 25-hydroxycholesterol (4 μM ...
-
bioRxiv - Immunology 2023Quote: ... injections every 3-4 days with 200 µg irrelevant antibody (clone 2A3, BioXCell), αPD-1 (clone RMP1-14 ...
-
bioRxiv - Cancer Biology 2020Quote: ... one group received 200 μg of PD-1 inhibitor (BioXCell, clone 29F.1A12) followed by saline and the combination treatment group received 200 μg of PD-1 inhibitor followed by 200 μg of F8-GITRL [Supplementary Table 4].
-
bioRxiv - Immunology 2023Quote: ... or 4-1BB (5 µg/ml, clone 3H3, BE0239) all from BioXCell. Unless otherwise stated ...
-
bioRxiv - Cancer Biology 2020Quote: ... with 200 μg of ◻PD-L1 (10F.9G2) or αPD-1 (RMP1-14) or αCTLA-4 (9H10) antibody or with isotype control antibodies (all from BioXcell) on days 9 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were washed in FACS buffer followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing 1:100 anti-CD16/32 (Fc block; BioXCell) to block non-specific binding ...
-
bioRxiv - Cancer Biology 2024Quote: ... and/or 5 mg/kg anti-CTLA-4 (clone 9H10, cat. BE0131, BioXcell). Antibodies were dissolved in PBS and administered via intraperitoneal injection (4 μl/g ...
-
bioRxiv - Immunology 2023Quote: ... LCMV-NP (self-conjugated to AF488 using Thermo Fisher AF488 labeling kit per manufacturer’s instructions, BioXcell, 1:50, clone VL-4).
-
bioRxiv - Immunology 2019Quote: ... For Th2 induction 1×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell) and αCD28 (10 μg mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... 2 to 3×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell), αCD28 (1 μg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... were injected intraperitoneally with monoclonal antibodies against PD-1 (RMP1-14, 250 μg per dose) and CLTA-4 (9D9, 100 μg per dose) (BioXCell, Lebanon, NH) in sterile PBS or a control PBS solution (25) ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-PD-1 (5 mg/kg, #BE0273, BioXCell, twice per week), abraxane (25 mg/kg ...
-
bioRxiv - Cancer Biology 2023Quote: ... 100μg/mouse anti-CD28 (clone PV-1, BioXcell, Cat#BE0015-5) or isotype (polyclonal Armenian hamster Armenian Hamster IgG ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Microbiology 2020Quote: ... (BioXcell, BP0075-1, 1 mg). Isotype matched IgG2a ...
-
bioRxiv - Immunology 2022Quote: ... 5 ug/ml Brefeldin A was supplemented 4 hrs before subsequent Fc blocking (2.4G2, BioXCell), surface antibody staining ...
-
bioRxiv - Immunology 2019Quote: ... with 5 μg purified anti-mouse IL-2 antibody (JES6-1, BioXcell) for 30 min at 37°C (molar ratio for IL2:anti-IL-2 is 2:1) ...
-
bioRxiv - Immunology 2022Quote: ... Cells were subsequently washed twice with PBS and incubated with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM, 1:500 dilution) for 30 min at room temperature ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2021Quote: ... The following antibodies were used for in vivo blocking experiments: anti-LFA-1α (M17/4) and anti-Mac-1 (M1/70) (both from Bio X Cell, West Lebanon, NH). The following antibodies or reagents were used for in vivo cell depletion ...
-
bioRxiv - Immunology 2022Quote: ... cells were stained with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM), anti-human CD58-AlexaFluor647 (BD Bioscience ...
-
bioRxiv - Immunology 2023Quote: ... The anti-IL2 contained a 1:1 mixture of S4B6 (BioXcell; Cat # BE0043-1) and JES6-1a12 (BioXcell ...
-
bioRxiv - Cancer Biology 2023Quote: ... or anti-PD-1 (RPM 1-14, BioXcell) and/or anti-CTLA4 (9H10 ...
-
bioRxiv - Cancer Biology 2021Quote: ... 3) 10 µg/kg anti-PD-1 mAb (BioXCell, Cat. No. BE0146, clone RMP1-14) IP every three days for the duration of the experiment ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Cancer Biology 2021Quote: ... mice were intraperitoneally treated with one dose of 1 mg CSF1 neutralizing antibody (clone 5A1; BioXCell, Lebanon, NH, USA) and sacrificed at 12 and 24 h after treatments.
-
bioRxiv - Immunology 2022Quote: ... and CD28 (1 μg/ml; clone PV-1; BioXCell). We cultured the T cells in DMEM medium (Gibco ...
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...